Back to Search
Start Over
Phase 2 trial of talabostat and docetaxel in patients with stage IIIb/IV NSCLC
- Source :
- Journal of Clinical Oncology. 23:7120-7120
- Publication Year :
- 2005
- Publisher :
- American Society of Clinical Oncology (ASCO), 2005.
-
Abstract
- 7120 Background: Talabostat (T) is an oral inhibitor of dipeptidyl peptidases such as fibroblast activation protein found on the stroma of tumors. Administration of T stimulates cytokine and chemok...
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........b8d57335c94b3c63652e63936ab93f3f
- Full Text :
- https://doi.org/10.1200/jco.2005.23.16_suppl.7120